Moderna $MRNA Surges 150% After Phase 3 Cancer Win
Moderna $MRNA Surges 150% After Phase 3 Cancer WinModerna shares exploded as much as 150% on Wednesday after the company and Merck said their personalized mRNA cancer vaccine succeeded in a late-stage...